Race, Ethnicity Categories Proposed for Drug Trials. (Responses May Differ)
Mechcatie, Elicabeth, Clinical Psychiatry News
ROCKVILLE, MD.--A standardized approach to collecting data in people from different ethnic and racial groups in new drug trials has been recommended by the Food and Drug Administration.
The proposal reflects the increased awareness that responses to drugs are not always uniform across the population.
The FDA's draft "Guidance for Industry" document provides recommendations on different categories of ethnic and racial demographic groups to use when collecting effectiveness and safety data in clinical trials. Using standardized categories when collecting such data "will enhance the early identification of differences in response among racial and ethnic groups during …
The rest of this article is only available to active members of Questia
Sign up now for a free, 1-day trial and receive full access to:
- Questia's entire collection
- Automatic bibliography creation
- More helpful research tools like notes, citations, and highlights
- Ad-free environment
Already a member? Log in now.
Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information:
Article title: Race, Ethnicity Categories Proposed for Drug Trials. (Responses May Differ).
Contributors: Mechcatie, Elicabeth - Author.
Magazine title: Clinical Psychiatry News.
Volume: 31.
Issue: 4
Publication date: April 2003.
Page number: 66.
© 2009 International Medical News Group.
COPYRIGHT 2003 Gale Group.
This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.
One moment ...
- Georgia
- Arial
- Times New Roman
- Verdana
- Courier/monospaced
Reset